Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 221
Filtrar
1.
Development ; 151(13)2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38940293

RESUMEN

Generation of hematopoietic stem and progenitor cells (HSPCs) ex vivo and in vivo, especially the generation of safe therapeutic HSPCs, still remains inefficient. In this study, we have identified compound BF170 hydrochloride as a previously unreported pro-hematopoiesis molecule, using the differentiation assays of primary zebrafish blastomere cell culture and mouse embryoid bodies (EBs), and we demonstrate that BF170 hydrochloride promoted definitive hematopoiesis in vivo. During zebrafish definitive hematopoiesis, BF170 hydrochloride increases blood flow, expands hemogenic endothelium (HE) cells and promotes HSPC emergence. Mechanistically, the primary cilia-Ca2+-Notch/NO signaling pathway, which is downstream of the blood flow, mediated the effects of BF170 hydrochloride on HSPC induction in vivo. Our findings, for the first time, reveal that BF170 hydrochloride is a compound that enhances HSPC induction and may be applied to the ex vivo expansion of HSPCs.


Asunto(s)
Diferenciación Celular , Hematopoyesis , Células Madre Hematopoyéticas , Pez Cebra , Animales , Células Madre Hematopoyéticas/efectos de los fármacos , Células Madre Hematopoyéticas/citología , Células Madre Hematopoyéticas/metabolismo , Ratones , Diferenciación Celular/efectos de los fármacos , Hematopoyesis/efectos de los fármacos , Receptores Notch/metabolismo , Transducción de Señal/efectos de los fármacos , Cuerpos Embrioides/citología , Cuerpos Embrioides/efectos de los fármacos , Cuerpos Embrioides/metabolismo , Cilios/metabolismo , Cilios/efectos de los fármacos , Blastómeros/citología , Blastómeros/metabolismo , Blastómeros/efectos de los fármacos , Células Cultivadas
2.
Gynecol Obstet Invest ; 85(1): 94-99, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31743930

RESUMEN

AIM: The objective of the present study was to investigate the development of mouse embryos and the chromosomal status after the pre-implantation treatment with paclitaxel (Taxol) based on the reports that indicate Taxol improves the developmental potential of vitrified human and mouse oocytes. METHODS: Outbred female mice were superovulated and in vitro fertilization (IVF) was carried out using sperms from the same strain. Two-cell stage mouse embryos were cultured in the presence of Taxol for 24 h. After the determination of a non-toxic dose of Taxol, embryo development in control and Taxol-treated groups was compared during 3.5 days post-IVF. The aneuploidy rate of embryos was assessed by fluorescence in situ hybridization for chromosomes 2 and 11. RESULTS: Development to morula and blastocyst stages was considerably enhanced following the addition of Taxol 0.01 µM compared to a similar situation in controls (p < 0.0001). Moreover, the degeneration rate was decreased following treatment with this concentration of Taxol (p < 0.01). The rate of aneuploidy in embryos and individual blastomeres did not vary between groups (p = 0.518 and 0.810 respectively). CONCLUSION: Pre-implantation treatment with Taxol 0.01 µM had a positive effect on the development to morula/blastocyst stages and decreased the degeneration rate without affecting the aneuploidy rate of chromosomes 2 and 11.


Asunto(s)
Blastocisto/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Paclitaxel/farmacología , Aneuploidia , Animales , Blastómeros/efectos de los fármacos , Implantación del Embrión , Femenino , Fertilización In Vitro , Hibridación Fluorescente in Situ , Ratones , Oocitos
3.
Int J Mol Sci ; 21(16)2020 Aug 12.
Artículo en Inglés | MEDLINE | ID: mdl-32806749

RESUMEN

Triclosan (TCS) is included in various healthcare products because of its antimicrobial activity; therefore, many humans are exposed to TCS daily. While detrimental effects of TCS exposure have been reported in various species and cell types, the effects of TCS exposure on early embryonic development are largely unknown. The aim of this study was to determine if TCS exerts toxic effects during early embryonic development using porcine parthenogenetic embryos in vitro. Porcine parthenogenetic embryos were cultured in in vitro culture medium with 50 or 100 µM TCS for 6 days. Developmental parameters including cleavage and blastocyst formation rates, developmental kinetics, and the number of blastomeres were assessed. To determine the toxic effects of TCS, apoptosis, oxidative stress, and mitochondrial dysfunction were assessed. TCS exposure resulted in a significant decrease in 2-cell rate and blastocyst formation rate, as well as number of blastomeres, but not in the cleavage rate. TCS also increased the number of apoptotic blastomeres and the production of reactive oxygen species. Finally, TCS treatment resulted in a diffuse distribution of mitochondria and decreased the mitochondrial membrane potential. Our results showed that TCS exposure impaired porcine early embryonic development by inducing DNA damage, oxidative stress, and mitochondrial dysfunction.


Asunto(s)
Blastocisto/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Partenogénesis/efectos de los fármacos , Porcinos/embriología , Triclosán/toxicidad , Animales , Apoptosis/efectos de los fármacos , Blastómeros/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Embrión de Mamíferos/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Estrés Oxidativo/efectos de los fármacos
4.
J Assist Reprod Genet ; 36(1): 99-111, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30430313

RESUMEN

PURPOSE: To assess the role of the genetic background, the culture medium supplements, and the presence of modulators of signaling pathways on mouse embryonic stem cell derivation from single blastomeres from 8-cell embryos. METHODS: Mice from permissive and non-permissive genetic backgrounds, different culture media supplements, knockout serum replacement (KSR) and N2B27, and the presence or absence of 2i treatment were used to derive mouse embryonic stem cells (mESC) from single blastomeres isolated from 8-cell embryos and from control embryos at the blastocyst stage. After the sixth passage, the putative mESC were analyzed by immunofluorescence to assess their pluripotency and, after in vitro differentiation induction, their ability to differentiate into derivatives of the three primary germ layers. Selected mESC lines derived from single blastomeres in the most efficient culture conditions were further characterized to validate their stemness. RESULTS: In control embryos, high mESC derivation efficiencies (70-96.9%) were obtained from permissive backgrounds or when embryos were cultured in medium complemented with 2i regardless of their genetic background. By contrast, only blastomeres isolated from embryos from permissive background cultured in KSR-containing medium complemented with 2i were moderately successful in the derivation of mESC lines (22.9-24.5%). Moreover, we report for the first time that B6CBAF2 embryos behave as permissive in terms of mESC derivation. CONCLUSIONS: Single blastomeres have higher requirements than whole blastocysts for pluripotency maintenance and mESC derivation. The need for 2i suggests that modulation of signaling pathways to recreate a commitment towards inner cell mass could be essential to efficiently derive mESC from single blastomeres.


Asunto(s)
Blastómeros/citología , Medios de Cultivo/farmacología , Técnicas de Cultivo de Embriones/métodos , Antecedentes Genéticos , Células Madre Embrionarias de Ratones/citología , Animales , Blastómeros/efectos de los fármacos , Blastómeros/metabolismo , Diferenciación Celular , Desarrollo Embrionario , Femenino , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Células Madre Embrionarias de Ratones/efectos de los fármacos , Células Madre Embrionarias de Ratones/metabolismo , Transducción de Señal
5.
Mol Hum Reprod ; 23(1): 25-33, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27733489

RESUMEN

STUDY QUESTION: Does fetuin-B inhibit premature zona pellucida (ZP) hardening in mouse oocytes in vitro and thus increase IVF rate? SUMMARY ANSWER: Supplementation of oocyte in vitro maturation (IVM) media with recombinant mouse fetuin-B (rmFetuB) increased fertilization rate without affecting mouse embryo development into blastocysts. WHAT IS KNOWN ALREADY: Mice deficient in fetuin-B are infertile owing to premature ZP hardening. Premature ZP hardening also occurs during oocyte IVM leading to decreased fertilization rate. STUDY DESIGN, SIZE, DURATION: We fertilized batches of 20-30 mouse metaphase II (Mll) stage oocytes from C57BL/6 mice with fresh sperm, and studied early embryo development until blastocyst hatching. PARTICIPANTS/MATERIALS, SETTING, METHODS: Oocytes were maintained with or without rmFetuB during IVM and IVF. Exogenous rmFetuB was added to media prior to oocyte isolation. ZP hardening was quantified by chymotrypsin digestion timing and by counting attached sperm. MAIN RESULTS AND THE ROLE OF CHANCE: In the absence of cumulus cells, rmFetuB dose-dependently inhibited ZP hardening and increased IVF rate (P = 0.039). Fetuin-B at ≥0.03 mg/ml also inhibited physiological, fertilization-triggered ZP hardening (indicated by increased sperm binding, P = 0.0002), without increasing embryo death. Exogenous rmFetuB increased IVF rate for up to 5 hours of IVM (P = 0.02 at 1 hour, P = 0.01 at 5 hours of IVM). LIMITATIONS, REASONS FOR CAUTION: Mll stage oocytes in this study were isolated from the ampullae of fetuin-B expressing mice. Thus, oocytes were protected against premature ZP hardening by endogenous fetuin-B. In humans and livestock, oocytes are usually isolated by follicle puncture before ovulation. In this situation, the deprivation of endogenous fetuin-B would occur earlier and the effect of exogenous fetuin-B in the IVF medium may be even more pronounced. Fertilization-triggered ZP hardening is essential for embryo development but in this study the effect of fetuin-B supplementation was only studied to blastocyst stage. Any influence of added fetuin-B on later embryo development after transplantation remains to be determined. WIDER IMPLICATIONS OF THE FINDINGS: The astacin-type protease ovastacin triggers definitive ZP hardening by cleaving the zona pellucida protein 2. Animal sera are known to inhibit premature ZP hardening. The addition of rFetuB to the culture medium of oocytes could increase IVF rates by the inhibition of premature ZP hardening. In this regard, the results could be useful for clinical activity. LARGE SCALE DATA: None. STUDY FUNDING/COMPETING INTERESTS: The research was supported by a grant from Deutsche Forschungsgemeinschaft and by the START program of the Medical Faculty of RWTH Aachen University. The authors ED, JF and WJD are named inventors on a patent application of RWTH Aachen University covering the use of fetuin-B in ovary and oocyte culture.


Asunto(s)
Fertilización In Vitro/métodos , Fetuína-B/farmacología , Técnicas de Maduración In Vitro de los Oocitos/métodos , Oocitos/efectos de los fármacos , Zona Pelúcida/efectos de los fármacos , Animales , Blastómeros/citología , Blastómeros/efectos de los fármacos , Blastómeros/metabolismo , Células del Cúmulo , Desarrollo Embrionario/efectos de los fármacos , Femenino , Regulación del Desarrollo de la Expresión Génica , Dureza , Masculino , Metaloproteasas/genética , Metaloproteasas/metabolismo , Ratones , Ratones Endogámicos C57BL , Oocitos/citología , Oocitos/crecimiento & desarrollo , Oocitos/metabolismo , Cultivo Primario de Células , Proteínas Recombinantes/farmacología , Transducción de Señal , Espermatozoides/citología , Espermatozoides/fisiología , Zona Pelúcida/química , Glicoproteínas de la Zona Pelúcida/genética , Glicoproteínas de la Zona Pelúcida/metabolismo
6.
Acta Vet Hung ; 64(3): 390-400, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27653435

RESUMEN

The mycotoxin T-2 has many harmful effects on mammalian cells and reproductive functions. In the present study, the in vitro effect of T-2 toxin on mouse blastocysts was examined. Embryos were cultured in media supplemented with 0.5, 0.75 and 1 ng/ml T-2. Different exposure times were applied [96 h (treatment I) or 24 h following 72 h in toxin-free media (treatment II)]. Blastomere number, nuclear chromatin status and blastocoel formation were investigated in blastocysts. Our data show that the effect of T-2 toxin may vary depending on the stage of the embryo at the start of exposure. At 96 h of exposure, the blastocysts had blastomeres with normal chromatin quality but their developmental potential was decreased. After 24 h of exposure applied following a 72-h culture, blastomeres had a higher level of chromatin damage, although their developmental potential was the same as in the control embryos. In both cases, decreased mitotic rate was found, which resulted in decreased blastomere number even at low toxin concentration.


Asunto(s)
Blastocisto/efectos de los fármacos , Blastómeros/efectos de los fármacos , Cromatina/efectos de los fármacos , Toxina T-2/toxicidad , Animales , Blastómeros/fisiología , Ratones
7.
Reprod Biomed Online ; 31(4): 577-80, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26206284

RESUMEN

This study proposed a quantitative evaluation of oxidative status (OS) in bovine embryos. Sixteen-cell stage embryos, cultured under 5% O2, were treated with oxidative stress inducer menadione (0, 1, 2.5 and 5 µmol/l) for 24 h. Blastocyst rate (BLR) was recorded and expanded blastocysts were stained with CellROX®Green (CRG; OS evaluation) and evaluated under epifluorescence microscopy (ratio of pixel/blastomere). A significant effect of menadione was observed for BLR (P = 0.0039), number of blastomeres/embryo (P < 0.0001) and OS (P < 0.001). Strong negative correlations were found between BLR and the number of blastomeres with OS evaluation, demonstrating the efficacy of this analysis to evaluate OS levels of IVF bovine embryos.


Asunto(s)
Embrión de Mamíferos/metabolismo , Estrés Oxidativo , Animales , Blastocisto/citología , Blastocisto/efectos de los fármacos , Blastocisto/metabolismo , Blastómeros/citología , Blastómeros/efectos de los fármacos , Blastómeros/metabolismo , Bovinos , Técnicas de Cultivo de Embriones , Embrión de Mamíferos/citología , Embrión de Mamíferos/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Desarrollo Embrionario/fisiología , Femenino , Fertilización In Vitro/veterinaria , Microscopía Fluorescente , Estrés Oxidativo/efectos de los fármacos , Vitamina K 3/toxicidad
8.
J Assist Reprod Genet ; 32(1): 127-36, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25381620

RESUMEN

PURPOSE: In the present study, fertilization and developmental potential of mouse oocytes matured in different conditions were tested. The efficiency of in vitro fertilization (IVF), pre-implantation development and some important aspects of cytokinesis during early cleavages are discussed. METHODS: In vivo matured (IVO), in vitro matured (IVM) and roscovitine-treated (IVM-Rosco) mouse oocytes were subjected to IVF under identical conditions. Three replicates per group were analyzed. Fertilization was identified by the presence of two pronuclei at 6-8 h post-fertilization. Evaluation of pre-implantation embryonic development was done daily from day 2 to day 5 and embryos were processed for analyses of chromatin, nuclear lamina, microtubules and centrosomal proteins by conventional and confocal fluorescence microscopy. RESULTS: Both IVM groups displayed lower fertilization rates when compared to in vivo controls. While IVO-derived embryos exhibit efficient and synchronous progression to the blastocyst stage, both IVM-derived embryos exhibit a delay in embryonic progression, and a lower blastocyst rate. Interestingly, IVM-Rosco M-II oocytes exhibited more blastomere symmetries and higher number of cells at the blastocyst stage than the IVM group with the most notable influence being on the centrosome-microtubule complex of blastomeres. CONCLUSION: Our study strongly indicates that when compared to spontaneously in vitro matured oocytes, treatment with roscovitine may partially enhance developmental competence by maintaining coordination between nuclear and cytoplasmic events. Further evidence is given of cytoskeletal biomarkers that can be identified during in vitro oocyte maturation conditions.


Asunto(s)
Desarrollo Embrionario , Fertilización In Vitro , Técnicas de Maduración In Vitro de los Oocitos , Oocitos/crecimiento & desarrollo , Animales , Blastocisto/efectos de los fármacos , Blastómeros/efectos de los fármacos , Puntos de Control del Ciclo Celular/efectos de los fármacos , Puntos de Control del Ciclo Celular/fisiología , Femenino , Humanos , Técnicas In Vitro , Ratones , Oocitos/efectos de los fármacos , Embarazo , Purinas/administración & dosificación , Roscovitina
9.
J Assist Reprod Genet ; 32(5): 789-95, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25788359

RESUMEN

PURPOSE: The aim of this study was to evaluate the correlation between embryonic early-cleavage status and the age of patients receiving either a GnRH agonist long protocol or a GnRH antagonist protocol. METHODS: This retrospective study included 534 patients undergoing a fresh cycle of oocyte retrieval and day-3 embryo transfer. Of the 534 patients treated, 331 received a GnRH agonist long stimulation protocol (GnRH agonist group) for ovarian stimulation and 203 patients received a GnRH antagonist protocol (GnRH antagonist group). RESULTS: By logistic regression analysis, the rate of embryonic early-cleavage was significantly decreased with increasing age of women in the agonist (P < 0.001) but not in antagonist groups (P = 0.61). Based on the results of this study, maternal age is a critical factor for embryonic early-cleavage in agonist protocol but not in antagonist protocol. The results also showed that early-cleavage embryos were of better quality and resulted in a higher pregnancy rate than late-cleavage embryos in the GnRH agonist group. However, embryo quality and pregnancy rate was not significantly different between early and late cleavage embryos in the GnRH antagonist group. CONCLUSIONS: We conclude that embryonic early-cleavage status is negatively correlated with aging in women receiving GnRH agonist long down-regulation but not in GnRH antagonist protocols. We also conclude that early cleavage of the zygote is not a reliable predictor for pregnancy potential using the GnRH antagonist protocol.


Asunto(s)
Blastómeros/citología , Fase de Segmentación del Huevo/citología , Embrión de Mamíferos/citología , Hormona Liberadora de Gonadotropina/agonistas , Hormona Liberadora de Gonadotropina/antagonistas & inhibidores , Oocitos/citología , Adulto , Blastómeros/efectos de los fármacos , Fase de Segmentación del Huevo/efectos de los fármacos , Implantación del Embrión , Transferencia de Embrión , Embrión de Mamíferos/efectos de los fármacos , Femenino , Fármacos para la Fertilidad Femenina/uso terapéutico , Fertilización In Vitro/métodos , Humanos , Infertilidad Femenina/tratamiento farmacológico , Oocitos/efectos de los fármacos , Inducción de la Ovulación , Embarazo , Índice de Embarazo , Estudios Retrospectivos , Resultado del Tratamiento
10.
Biol Reprod ; 91(3): 62, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25031360

RESUMEN

Transforming growth factor beta (TGFbeta) superfamily signaling controls various aspects of female fertility. However, the functional roles of the TGFbeta-superfamily cognate signal transduction pathway components (e.g., SMAD2/3, SMAD4, SMAD1/5/8) in early embryonic development are not completely understood. We have previously demonstrated pronounced embryotrophic actions of the TGFbeta superfamily member-binding protein, follistatin, on oocyte competence in cattle. Given that SMAD4 is a common SMAD required for both SMAD2/3- and SMAD1/5/8-signaling pathways, the objectives of the present studies were to determine the temporal expression and functional role of SMAD4 in bovine early embryogenesis and whether embryotrophic actions of follistatin are SMAD4 dependent. SMAD4 mRNA is increased in bovine oocytes during meiotic maturation, is maximal in 2-cell stage embryos, remains elevated through the 8-cell stage, and is decreased and remains low through the blastocyst stage. Ablation of SMAD4 via small interfering RNA microinjection of zygotes reduced proportions of embryos cleaving early and development to the 8- to 16-cell and blastocyst stages. Stimulatory effects of follistatin on early cleavage, but not on development to 8- to 16-cell and blastocyst stages, were observed in SMAD4-depleted embryos. Therefore, results suggest SMAD4 is obligatory for early embryonic development in cattle, and embryotrophic actions of follistatin on development to 8- to 16-cell and blastocyst stages are SMAD4 dependent.


Asunto(s)
Blastocisto/metabolismo , Ectogénesis , Folistatina/metabolismo , Regulación del Desarrollo de la Expresión Génica , Proteína Smad4/metabolismo , Mataderos , Alfa-Amanitina/farmacología , Animales , Blastocisto/citología , Blastocisto/efectos de los fármacos , Blastómeros/citología , Blastómeros/efectos de los fármacos , Blastómeros/metabolismo , Bovinos , Ectogénesis/efectos de los fármacos , Técnicas de Cultivo de Embriones , Femenino , Fertilización In Vitro , Técnica del Anticuerpo Fluorescente Indirecta , Perfilación de la Expresión Génica , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Silenciador del Gen , Técnicas de Maduración In Vitro de los Oocitos , Inhibidores de la Síntesis del Ácido Nucleico/farmacología , ARN Mensajero/metabolismo , ARN Interferente Pequeño , Proteína Smad4/antagonistas & inhibidores , Proteína Smad4/genética
11.
Hum Reprod ; 29(8): 1739-48, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24963166

RESUMEN

STUDY QUESTION: Can transforming growth factor ß (TGFß) inhibition promote ground state pluripotency of embryonic stem cells (ESCs) from single blastomeres (SBs) of cleavage embryos in different mouse stains? SUMMARY ANSWER: Small molecule suppression of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) and TGFß signaling (designated as R2i) can enhance the generation of mouse ESCs from SBs of different cleavage stage embryos compared with the dual suppression of ERK1/2 and glycogen synthase kinase 3 (GSK3), designated as 2i, regardless of the strain of mouce. WHAT IS KNOWN ALREADY: It is known that chemical inhibition of TGFß promotes ground state pluripotency in the generation and sustenance of naïve ES cells from mouse blastocysts compared with the well-known 2i condition. However, the positive effect of this inhibition on mouse ESCs from early embryonic SBs remains obscure. STUDY DESIGN, SIZE, DURATION: We used 155 cleavage-stage mouse embryos to optimize the culture conditions for blastocyst development. Then, to assess the effects of R2i and 2i on ESC generation from SBs, we cultured isolated SBs in 2i and R2i for 10 days. SBs were replated under the same conditions to produce ESCs. In total, 46 embryos and 321 SBs from two- to eight-cell stages were recovered from NMRI and BALB/c mouse strains and used in this study. PARTICIPANTS/MATERIALS, SETTING, METHODS: Blastomeres from 2- to 8-cell stage mouse embryos were dispersed and individually seeded into a 96-well plates that included mitotically inactivated feeder cells. ESCs were generated in B27N2 defined medium supplemented with R2i or 2i. Randomly selected ESC lines, generated from SBs of each stage, were assessed for pluripotency and germ-line transmission. MAIN RESULTS AND THE ROLE OF CHANCE: We demonstrated that dual inhibition of ERK1/2 and TGFß (R2i) enhanced efficient blastocyst development and efficient establishment of ESCs from SB of 2- to 8-cell stage mouse embryos compared with the dual inhibition of ERK1/2 and GSK3 (2i) regardless of the embryonic stage and strain of mice. The proportions of SBs that produced ESC were 50-60 versus 20-30%. LIMITATIONS, REASONS FOR CAUTION: This study was done with mouse embryos, it is not known whether these findings are transferable to humans. WIDER IMPLICATIONS OF THE FINDINGS: These findings resulted in an increased efficiency of ESC generation from one biopsied blastomere for autogeneic or allogeneic matched pluripotent cells without the need to destroy viable embryos. The results also provided information about the developmental capacity of early embryonic blastomeres. STUDY FUNDING/COMPETING INTERESTS: This study was funded by grants provided from Royan Institute, the Iranian Council of Stem Cell Research and Technology and the Iran National Science Foundation. The authors have no conflict of interest to declare.


Asunto(s)
Blastómeros/efectos de los fármacos , Embrión de Mamíferos/efectos de los fármacos , Factor de Crecimiento Transformador beta/antagonistas & inhibidores , Animales , Blastómeros/metabolismo , Diferenciación Celular , Técnicas de Cultivo de Embriones , Embrión de Mamíferos/citología , Desarrollo Embrionario/efectos de los fármacos , Células Madre Embrionarias/citología , Células Madre Embrionarias/efectos de los fármacos , Femenino , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C
12.
Environ Sci Technol ; 48(17): 10398-405, 2014 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-25102367

RESUMEN

This study epigenetically examined the effect of fluoride on early embryos of Kunming mice administered with 0, 20 (low), 60 (medium), and 120 mg/L (high) sodium fluoride (NaF). The results showed that NaF repressed oocyte maturation, fertilization and blastocyst formation in all NaF-treated groups. Meanwhile, TUNEL assay showed that embryo apoptosis was induced dramatically in blastocyst stage at either low or medium doses, and in 8-cell stage at high dose, compared to the control, suggesting a dose-dependent effect. Furthermore, the immunostaining displayed global increases of DNA methylation, H3K9m2 and H3K4m2 with increasing dose, which were consistent with gene expression results, exhibiting general increases of DNMT1, DNMT3a, G9a, LSD1, and MLL1 and a reduction of JHDM2a in transcription and protein levels. More closely, the differential methylation domain in parentally imprinted gene H19 showed low methylation, while materanlly imprinted gene IGF2 showed high methylaiton in NaF-treated groups compared to the control group, which corresponded with high expression of H19 and low expression of IGF2 confirmed by qPCR. Collectively, we demonstrated that fluoride epigenetically impaired mouse oocyte maturation and embryonic development, supplying a better knowledge of fluoride in toxicology and a deeper evaluation of its potential influence in physiological and clinical implications.


Asunto(s)
Apoptosis/genética , Metilación de ADN/genética , Embrión de Mamíferos/metabolismo , Procesamiento Proteico-Postraduccional/genética , Fluoruro de Sodio/farmacología , Animales , Apoptosis/efectos de los fármacos , Secuencia de Bases , Blastómeros/citología , Blastómeros/efectos de los fármacos , Blastómeros/metabolismo , Islas de CpG/genética , Metilación de ADN/efectos de los fármacos , Embrión de Mamíferos/citología , Embrión de Mamíferos/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Desarrollo Embrionario/genética , Femenino , Fertilización/efectos de los fármacos , Fertilización/genética , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Histonas/metabolismo , Humanos , Etiquetado Corte-Fin in Situ , Técnicas de Maduración In Vitro de los Oocitos , Factor II del Crecimiento Similar a la Insulina/genética , Masculino , Ratones , Datos de Secuencia Molecular , Embarazo , Procesamiento Proteico-Postraduccional/efectos de los fármacos , ARN Largo no Codificante , ARN Mensajero/genética , ARN Mensajero/metabolismo
13.
Reprod Biomed Online ; 26(5): 470-6, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23507132

RESUMEN

The use of open carriers for embryo vitrification has raised safety concerns and therefore vitrification in closed systems has been proposed. However, the drop in the cooling rate emerges as a major drawback. The objective of the present study was to compare the efficiency of vitrification in open versus closed conditions. Blastocysts were randomly allocated either to open ultra-rapid vitrification (group I) or closed aseptic vitrification (group II). In group I, blastocysts were exposed to two solutions of ethylene glycol/dimethylsulphoxide (10%/10% and 20%/20%), while in group II, blastocysts were pretreated with a solution of lower concentration (5%/5%). A total of 208 and 224 vitrification-warming cycles were performed for groups I and II, respectively. Both groups were equal in terms of maternal age, sperm parameters and number and quality of blastocysts vitrified, warmed and transferred per cycle. Importantly, there was no significant difference between the groups in the analysed outcomes; embryo survival rate (84.1% versus 82.1%), clinical pregnancy rate (45.9% versus 42.4%), implantation rate (25.6% versus 24.5%), cycle cancellation rate (6.7% versus 8.5%) and live birth rate (41.2% versus 41.0%). These data suggest that ultra-rapid vitrification may be replaced by aseptic vitrification without affecting clinical efficiency.


Asunto(s)
Blastómeros/fisiología , Criopreservación/métodos , Donación de Oocito/métodos , Índice de Embarazo , Vitrificación , Adulto , Blastómeros/efectos de los fármacos , Crioprotectores/farmacología , Dimetilsulfóxido/farmacología , Relación Dosis-Respuesta a Droga , Glicol de Etileno/farmacología , Femenino , Humanos , Embarazo , Resultado del Embarazo , Estudios Prospectivos
14.
Reprod Fertil Dev ; 25(8): 1174-84, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23231764

RESUMEN

Dibutyl phthalate (DBP), a widely used phthalate, is known to cause many serious diseases, especially in the reproductive system. However, little is known about the effects of its metabolite, mono-n-butyl phthalate (MBP), on preimplantation embryo development. In the present study, we found that treatment of embryos with 10⁻³ M MBP impaired developmental competency, whereas exposure to 10⁻4 M MBP delayed the progression of preimplantation embryos to the blastocyst stage. Furthermore, reactive oxygen species (ROS) levels in embryos were significantly increased following treatment with 10⁻³ M MBP. In addition, 10⁻³ M MBP increased apoptosis via the release of cytochrome c, whereas immunofluorescent analysis revealed that exposure of preimplantation embryos to MBP concentration-dependently (10⁻5, 10⁻4 and 10⁻³ M) decreased DNA methylation. Together, the results indicate a possible relationship between MBP exposure and developmental failure in preimplantation embryos.


Asunto(s)
Apoptosis/efectos de los fármacos , Blastocisto/efectos de los fármacos , Ectogénesis/efectos de los fármacos , Disruptores Endocrinos/toxicidad , Estrés Oxidativo/efectos de los fármacos , Ácidos Ftálicos/toxicidad , Solventes/toxicidad , Animales , Blastocisto/citología , Blastocisto/metabolismo , Blastómeros/citología , Blastómeros/efectos de los fármacos , Blastómeros/metabolismo , Fase de Segmentación del Huevo/citología , Fase de Segmentación del Huevo/efectos de los fármacos , Fase de Segmentación del Huevo/metabolismo , Metilación de ADN/efectos de los fármacos , Técnicas de Cultivo de Embriones , Femenino , Fertilización In Vitro , Masculino , Ratones Endogámicos ICR , Mórula/citología , Mórula/efectos de los fármacos , Mórula/metabolismo , Concentración Osmolar , Plastificantes/toxicidad , Especies Reactivas de Oxígeno/metabolismo
15.
J Reprod Dev ; 59(5): 442-9, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23748715

RESUMEN

The efficiency of cloning by somatic cell nuclear transfer (SCNT) has remained low. In most cloned embryos, epigenetic reprogramming is incomplete, and usually the genome is hypermethylated. The DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) could improve the developmental competence of cow, pig, cat and human SCNT embryos in previous studies. However, the parameters of 5-aza-dC treatment among species are different, and whether 5-aza-dC could enhance the developmental competence of porcine cloned embryos has still not been well studied. Therefore, in this study, we treated porcine fetal fibroblasts (PFF) that then were used as donor nuclei for nuclear transfer or fibroblast-derived reconstructed embryos with 5-aza-dC, and the concentration- and time-dependent effects of 5-aza-dC on porcine cloned embryos were investigated by assessing pseudo-pronucleus formation, developmental potential and pluripotent gene expression of these reconstructed embryos. Our results showed that 5-aza-dC significantly reduced the DNA methylation level in PFF (0 nM vs. 10 nM vs. 25 nM vs. 50 nM, 58.70% vs. 37.37% vs. 45.43% vs. 39.53%, P<0.05), but did not improve the blastocyst rate of cloned embryos derived from these cells. Treating cloned embryos with 25 nM 5-aza-dC for 24 h significantly enhanced the blastocyst rate compared with that of the untreated group. Furthermore, treating cloned embryos, but not donor cells, significantly promoted pseudo-pronucleus formation at 4 h post activation (51% for cloned embryos treated, 34% for donor cells treated and 36% for control, respectively, P<0.05) and enhanced the expression levels of pluripotent genes (Oct4, Nanog and Sox2) up to those of in vitro fertilized embryos during embryo development. In conclusion, treating cloned embryos, but not donor cells, with 5-aza-dC enhanced the developmental competence of porcine cloned embryos by promotion of pseudo-pronucleus formation and improvement of pluripotent gene expression.


Asunto(s)
Azacitidina/análogos & derivados , Blastómeros/efectos de los fármacos , Clonación de Organismos/veterinaria , Metilación de ADN/efectos de los fármacos , Ectogénesis/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Sus scrofa , Mataderos , Animales , Azacitidina/farmacología , Blastocisto/efectos de los fármacos , Blastocisto/enzimología , Blastocisto/metabolismo , Blastómeros/enzimología , Blastómeros/metabolismo , Células Cultivadas , ADN (Citosina-5-)-Metiltransferasa 1 , ADN (Citosina-5-)-Metiltransferasas/antagonistas & inhibidores , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Decitabina , Regulación hacia Abajo/efectos de los fármacos , Técnicas de Cultivo de Embriones/veterinaria , Epigénesis Genética/efectos de los fármacos , Femenino , Feto/citología , Fibroblastos/citología , Fibroblastos/efectos de los fármacos , Fibroblastos/enzimología , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Técnicas de Maduración In Vitro de los Oocitos/veterinaria , Masculino , Técnicas de Transferencia Nuclear/veterinaria , ARN Mensajero/metabolismo
16.
Dev Biol ; 355(2): 313-23, 2011 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-21575623

RESUMEN

Mechanisms that regulate the number of cells constituting the body have remained largely elusive. We approached this issue in the ascidian, Halocynthia roretzi, which develops into a tadpole larva with a small number of cells. The embryonic cells divide 11 times on average from fertilization to hatching. The number of cell division rounds varies among tissue types. For example, notochord cells divide 9 times and give rise to large postmitotic cells in the tadpole. The number of cell division rounds in partial embryos derived from tissue-precursor blastomeres isolated at the 64-cell stage also varied between tissues and coincided with their counterparts in the intact whole embryos to some extent, suggesting tissue-autonomous regulation of cell division. Manipulation of cell fates in notochord, nerve cord, muscle, and mesenchyme lineage cells by inhibition or ectopic activation of the inductive FGF signal changed the number of cell divisions according to the altered fate. Knockdown and missexpression of Brachyury (Bra), an FGF-induced notochord-specific key transcription factor for notochord differentiation, indicated that Bra is also responsible for regulation of the number of cell division rounds, suggesting that Bra activates a putative mechanism to halt cell division at a specific stage. The outcome of precocious expression of Bra suggests that the mechanism involves a putative developmental clock that is likely shared in blastomeres other than those of notochord and functions to terminate cell division at three rounds after the 64-cell stage. Precocious expression of Bra has no effect on progression of the developmental clock itself.


Asunto(s)
Comunicación Celular/fisiología , División Celular/fisiología , Desarrollo Embrionario/fisiología , Proteínas Fetales/metabolismo , Especificidad de Órganos/fisiología , Transducción de Señal/fisiología , Proteínas de Dominio T Box/metabolismo , Urocordados/embriología , Animales , Blastómeros/efectos de los fármacos , Blastómeros/metabolismo , Factores de Crecimiento de Fibroblastos/farmacología , Oligonucleótidos Antisentido , Transducción de Señal/efectos de los fármacos , Imagen de Lapso de Tiempo
17.
Ontogenez ; 43(2): 94-102, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-22650075

RESUMEN

Mouse single-cell embryos exhibit robust Regulatory Volume Decrease (RVD). In what manner the very early mammalian embryo following zygote stage is appreciably altered by the anisotonic extracellular solution is, as yet, totally unclear. Little attention was paid to this direction since there was no way to determine the blastomere volume. This work has served to quantitatively investigate the osmotic response of bicellular mouse embryos employing Laser Scanning Microtomography (LSM) followed with three-dimensional reconstruction (3 DR). We have shown that bicellular mouse embryos in hypotonic Dulbecco's experience RVD. Embryonic cells subjected to hyposmolar exhibit rapid osmotic swelling followed by gradual shrinking back toward their original volume. The van't Hoff law defines swelling phase with the effective hydraulic conductivity of 0.3 micron x min(-1) x atm(-1). Water release during RVD in bicellular mouse embryos is abolished by Cytochalasin B (Cyto B) and the volume recovery is insensitive to ouabain treatment.


Asunto(s)
Blastómeros/fisiología , Embrión de Mamíferos/fisiopatología , ATPasa Intercambiadora de Sodio-Potasio/fisiología , Animales , Blastómeros/efectos de los fármacos , Blastómeros/enzimología , Permeabilidad de la Membrana Celular , Tamaño de la Célula , Citocalasina B/farmacología , Embrión de Mamíferos/efectos de los fármacos , Embrión de Mamíferos/enzimología , Soluciones Hipotónicas , Imagenología Tridimensional , Ratones , Microscopía Confocal , Presión Osmótica , Ouabaína/farmacología , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Agua/metabolismo
18.
Mol Cell Biochem ; 353(1-2): 283-90, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21461911

RESUMEN

The expression of at least some biomarkers of toxicity is generally thought to precede the appearance of frank pathology. In the context of developmental toxicity, certain early indicators may be predictive of later drastic outcome. The search for predictive biomarkers of toxicity in the cells (blastomeres) of an early embryo can benefit from the fact that for normal development to proceed, the maintenance of blastomere cellular integrity during the process of transition from an embryo to a fully functional organism is paramount. Actin microfilaments are integral parts of blastomeres in the developing zebrafish embryo and contribute toward the proper progression of early development (cleavage and epiboly). In early embryos, the filamentous actin (F-actin) is present and helps to define the boundary of each blastomere as they remain adhered to each other. In our studies, we observed that when blastomeric F-actin is depolymerized by agents like gelsolin, the blastomeres lose cellular integrity, which results in abnormal larvae later in development. There are a variety of toxicants that depolymerize F-actin in early mammalian embryos, the later consequences of which are, at present, not known. We propose that very early zebrafish embryos (~5-h old) exposed to such toxicants will also respond in a like manner. In this review, we discuss the potential use of F-actin disruption as a predictive biomarker of developmental toxicity in zebrafish.


Asunto(s)
Actinas/metabolismo , Biomarcadores/metabolismo , Blastómeros/metabolismo , Embrión no Mamífero/metabolismo , Animales , Blastómeros/efectos de los fármacos , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/embriología , Contaminantes Ambientales/toxicidad , Modelos Biológicos , Dibenzodioxinas Policloradas/toxicidad , Pez Cebra/embriología , Pez Cebra/metabolismo
19.
Nature ; 434(7031): 391-5, 2005 Mar 17.
Artículo en Inglés | MEDLINE | ID: mdl-15772664

RESUMEN

One of the unanswered questions in mammalian development is how the embryonic-abembryonic axis of the blastocyst is first established. It is possible that the first cleavage division contributes to this process, because in most mouse embryos the progeny of one two-cell blastomere primarily populate the embryonic part of the blastocyst and the progeny of its sister populate the abembryonic part. However, it is not known whether the embryonic-abembryonic axis is set up by the first cleavage itself, by polarity in the oocyte that then sets the first cleavage plane with respect to the animal pole, or indeed whether it can be divorced entirely from the first cleavage and established in relation to the animal pole. Here we test the importance of the orientation of the first cleavage by imposing an elongated shape on the zygote so that the division no longer passes close to the animal pole, marked by the second polar body. Non-invasive lineage tracing shows that even when the first cleavage occurs along the short axis imposed by this experimental treatment, the progeny of the resulting two-cell blastomeres tend to populate the respective embryonic and abembryonic parts of the blastocyst. Thus, the first cleavage contributes to breaking the symmetry of the embryo, generating blastomeres with different developmental characteristics.


Asunto(s)
Blastocisto/citología , Tipificación del Cuerpo , Cigoto/citología , Cigoto/crecimiento & desarrollo , Animales , Blastocisto/efectos de los fármacos , Blastómeros/citología , Blastómeros/efectos de los fármacos , División Celular/efectos de los fármacos , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Cromatina/metabolismo , Citocalasina D/farmacología , Femenino , Fertilización , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Cigoto/efectos de los fármacos
20.
Dev Biol ; 329(1): 152-66, 2009 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-19382296

RESUMEN

During the molluscan evolution leading to the bivalves, the single dorsal shell was doubled. To elucidate the molecular developmental basis underlying this prominent morphological transition, we described the cell cleavage and expression patterns of three genes, brachyury, engrailed, and dpp in the Japanese spiny oyster Saccostrea kegaki, and examined the function of dpp in this species. The cleavage pattern of the S. kegaki embryo was nearly the same as the previously described pattern of other bivalve species, suggesting that the pattern itself is highly important for the establishment or the maintenance of the bivalve body plan. The expression pattern of a brachyury homolog in S. kegaki (SkBra) was similar to the pattern in gastopods even at the single cell level despite the deep divergence of gastropods and bivalves. Engrailed and dpp were previously found to be expressed around the shell anlagen in gastropods. Like that of gastropods, an engrailed homolog in S. kegaki (SkEn) was found to be expressed around the shell anlagen. However, the dpp homologin S. kegaki (SkDpp) was expressed only in the cells along the dorsal midline. ZfBMP4 treatment experiments revealed the importance of dpp in establishing the characteristic shape of the bivalve shell anlagen.


Asunto(s)
Evolución Biológica , Bivalvos/embriología , Bivalvos/genética , Moluscos/embriología , Moluscos/genética , Animales , Blastómeros/efectos de los fármacos , Proteína Morfogenética Ósea 4/genética , Proteína Morfogenética Ósea 4/farmacología , Linaje de la Célula , Relación Dosis-Respuesta a Droga , Embrión no Mamífero , Expresión Génica/efectos de los fármacos , Hibridación in Situ , Modelos Biológicos , Proteínas Recombinantes/farmacología , Pez Cebra/genética , Pez Cebra/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA